Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Considering $1.5 Trillion Plan to Stimulate Innovation

publication date: Dec 2, 2010
China will soon announce a plan to invest a massive $1.5 trillion over five years, with the goal of transforming seven industries into world-class leaders in innovative technology. Biotechnology is one of the target industries. Unlike most of the strategies presently in place for creating innovation, the plan does not call for huge government subsidies, but relies instead on creating incentives for bank lending, corporate investment and help from local governments. It is thought that China will cut the income tax rate in half – to 7.5% – for investors in the industries. More details....


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital